Fig. 4: Analysis of thrombosis rate using QRISK3 score.
From: QRISK3 score is predictive of thrombotic risk in patients with myeloproliferative neoplasms
Stratification according to QRISK3 of ≽ or <7.5% for (A) the whole MPN cohort (B) the essential thrombocythaemia cohort and (C) the polycythaemia vera cohort.
